之江生物：开立募集资金专户并签订四方监管协议

Core Viewpoint - The company has successfully raised a total of 2.104 billion yuan through its initial public offering, with a net amount of 1.942 billion yuan allocated for specific projects [1] Fundraising and Management - The company has established a dedicated account at China Merchants Bank for the management of the raised funds, specifically for the "Japan Intelligent Manufacturing Project" [1] - A four-party supervision agreement has been signed among the company, its wholly-owned subsidiary Chuan Yue Co., Ltd., China Merchants Bank, and Guotai Junan Securities to regulate the use of the funds [1] - As of November 28, 2025, the balance in the dedicated account is reported to be 0 USD/0 JPY [1] - The agreement outlines detailed responsibilities, fund usage supervision, and information inquiry protocols among the parties involved [1]